Home » About the AACR » Newsroom »
Next-generation sequencing for minimal residual disease was highly sensitive and more accurate than flow cytometry and monitoring of B-cell...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) and Pelotonia announced the establishment of a new grants...
PHILADELPHIA – A diet involving short-term, severe calorie restriction was safe, feasible, and resulted in a decrease of blood...
AACR expresses appreciation to Janet Woodcock, MD, for her excellent stewardship as FDA’s Acting Commissioner for the past 10...
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
Recognition to occur at SITC Annual Meeting in Washington, D.C. PHILADELPHIA – The American Association for Cancer Research (AACR)...
PHILADELPHIA – Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy)...
PHILADELPHIA – Younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older...
10 members of the AACR elected, including Fellow of the AACR Academy Drew Pardoll, MD, PhD PHILADELPHIA – The...
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...